je.st
news
Home
› Metabolic Solutions Development Company Announces Publication Of Data Describing Potential For New Drugs To Maintain Pancreatic Beta-Cells In Treating Diabetes
Metabolic Solutions Development Company Announces Publication Of Data Describing Potential For New Drugs To Maintain Pancreatic Beta-Cells In Treating Diabetes
2013-06-05 06:24:19| drugdiscoveryonline News Articles
Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data in a recent issue of the scientific journal PLOS ONE (http://dx.plos.org/10.1371/journal.pone.0062012) on the effects of a new drug for type 2 diabetes in restoring insulin sensitivity and insulin content in human beta- (b-) cells
Tags: data
company
development
publication
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|